These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 15574781

  • 1. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J, O'brate A, Zelnak A, Giannakakou P.
    Cancer Res; 2004 Dec 01; 64(23):8708-14. PubMed ID: 15574781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 4. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J, Liu P, Mao H, Wanga A, Zhang X.
    Oncol Rep; 2009 Jun 01; 21(6):1605-10. PubMed ID: 19424643
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A, Buckman R, Kerbel RS.
    Cancer Res; 1997 Jun 15; 57(12):2388-93. PubMed ID: 9192815
    [Abstract] [Full Text] [Related]

  • 7. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr 15; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin.
    Umezu T, Shibata K, Kajiyama H, Terauchi M, Ino K, Nawa A, Kikkawa F.
    Int J Gynecol Pathol; 2008 Apr 15; 27(2):207-12. PubMed ID: 18317222
    [Abstract] [Full Text] [Related]

  • 10. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
    Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC.
    Cancer Res; 2003 Jan 01; 63(1):230-5. PubMed ID: 12517802
    [Abstract] [Full Text] [Related]

  • 11. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z.
    Gynecol Oncol; 2010 Oct 01; 119(1):125-30. PubMed ID: 20624637
    [Abstract] [Full Text] [Related]

  • 12. Activation of p34cdc2 coincident with taxol-induced apoptosis.
    Donaldson KL, Goolsby GL, Kiener PA, Wahl AF.
    Cell Growth Differ; 1994 Oct 01; 5(10):1041-50. PubMed ID: 7848905
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis.
    Dan HC, Jiang K, Coppola D, Hamilton A, Nicosia SV, Sebti SM, Cheng JQ.
    Oncogene; 2004 Jan 22; 23(3):706-15. PubMed ID: 14737105
    [Abstract] [Full Text] [Related]

  • 14. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
    Mita AC, Mita MM, Nawrocki ST, Giles FJ.
    Clin Cancer Res; 2008 Aug 15; 14(16):5000-5. PubMed ID: 18698017
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
    Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P.
    Cancer Res; 2006 Apr 15; 66(8):4263-72. PubMed ID: 16618750
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.
    Giannakakou P, Poy G, Zhan Z, Knutsen T, Blagosklonny MV, Fojo T.
    Oncogene; 2000 Jun 22; 19(27):3078-85. PubMed ID: 10871860
    [Abstract] [Full Text] [Related]

  • 17. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
    George JA, Chen T, Taylor CC.
    Cancer Res; 2005 Nov 15; 65(22):10381-8. PubMed ID: 16288028
    [Abstract] [Full Text] [Related]

  • 18. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
    Chen JG, Yang CP, Cammer M, Horwitz SB.
    Cancer Res; 2003 Nov 15; 63(22):7891-9. PubMed ID: 14633718
    [Abstract] [Full Text] [Related]

  • 19. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 15; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 20. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M, Latham DE, Delaney MA, Chakravarti A.
    Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.